Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation ; volume:13 ; number:1 ; day:17 ; month:11 ; year:2023 ; pages:1-10 ; date:12.2023
Scientific reports ; 13, Heft 1 (17.11.2023), 1-10, 12.2023
- Creator
-
Santos, Thais Oliveira Claizoni dos
Santos Ferreira, Carlos Eduardo dos
Mangueira, Cristóvão Luis Pitangueira
Ammirati, Adriano Luiz
Scherer, Patricia Faria
Doher, Marisa Petrucelli
Matsui, Thais Nemoto
Santos, Bento Fortunato Cardoso dos
Pereira, Virgílio Gonçalves
Batista, Marcelo Costa
Monte, Julio Cesar Martins
Santos, Oscar Fernando Pavão
Souza Durão, Marcelino de
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-47644-1
- URN
-
urn:nbn:de:101:1-2024020512125321153952
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Santos, Thais Oliveira Claizoni dos
- Santos Ferreira, Carlos Eduardo dos
- Mangueira, Cristóvão Luis Pitangueira
- Ammirati, Adriano Luiz
- Scherer, Patricia Faria
- Doher, Marisa Petrucelli
- Matsui, Thais Nemoto
- Santos, Bento Fortunato Cardoso dos
- Pereira, Virgílio Gonçalves
- Batista, Marcelo Costa
- Monte, Julio Cesar Martins
- Santos, Oscar Fernando Pavão
- Souza Durão, Marcelino de
- SpringerLink (Online service)
Other Objects (12)
Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial
Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration
Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients
Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration
Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial
Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration
Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients
Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration
Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial
Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration
Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients